![Omid Farokhzad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omid Farokhzad
Amministratore Delegato presso SEER, INC.
Patrimonio netto: 8 M $ in data 31/03/2025
Profilo
Fondatore di 5 diverse aziende, tra cui: Seer, Inc. (California), Selecta Biosciences, Inc. e DNIB Unwind, Inc. Omid C. Farokhzad è un imprenditore ed è presidente e amministratore delegato di Seer, Inc. (California) (che ha fondato nel 2017). È anche nel consiglio di amministrazione di Placon Therapeutics, Inc. Nella sua carriera passata è stato presidente di Selecta Biosciences, Inc. (ha fondato la società nel 2007), professore associato alla Harvard Medical School, direttore di DNIB Unwind, Inc. e direttore di Tarveda Therapeutics, Inc. Il Dr. Farokhzad ha ricevuto un dottorato e una laurea alla Boston University School of Medicine e un MBA al Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SEER, INC. 87,67% | 31/12/2024 | 3.555.195 ( 87,67% ) | 6 M $ | 31/03/2025 |
SEER, INC. CLASS A 1,17% | 18/02/2025 | 640.749 ( 1,17% ) | 1 M $ | 31/03/2025 |
| 10/07/2024 | 194.740 ( 0,75% ) | 654 326 $ | 31/03/2025 |
Ultime notizie su Omid Farokhzad
Posizioni attive di Omid Farokhzad
| Società | Posizione | Inizio |
|---|---|---|
| SEER, INC. | Amministratore Delegato | 01/03/2018 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Direttore/Membro del Consiglio | - |
Xlink Therapeutics, Inc. | Fondatore | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Fondatore | - |
Xira Connect, Inc. | Direttore/Membro del Consiglio | 01/08/2019 |
Precedenti posizioni note di Omid Farokhzad
| Società | Posizione | Fine |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 25/11/2024 |
| DYNC SPL | Presidente | 01/06/2022 |
| CARTESIAN THERAPEUTICS, INC. | Fondatore | 19/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Fondatore | 01/01/2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Omid Farokhzad
Boston University School of Medicine | Doctorate Degree |
MIT Sloan School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SEER, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Technology Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Dynamics Special Purpose Corp. is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded on March 1, 2021 and is headquartered in Redwood City, CA. | Finance |
Xlink Therapeutics, Inc. | |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Health Technology |
Xira Connect, Inc. | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
- Borsa valori
- Insiders
- Omid Farokhzad
